Pull to refresh
Logo
Court approves generic drug settlement distribution plan

Court approves generic drug settlement distribution plan

Rule Changes

Consumers who bought certain generic drugs from 2009 to 2019 can file claims

Today: Court approves distribution plan

Overview

Updated 2 hours ago

The U.S. District Court for the District of Connecticut approved a plan to distribute settlement funds from generic drug manufacturers accused of conspiring to inflate prices. Consumers who bought certain generic prescription drugs in the United States between May 2009 and December 2019 can now file claims for compensation.

The settlements, totaling more than $565 million, resolve allegations that manufacturers including Sandoz, Glenmark, and Apotex colluded to raise prices on common generic medications. The claims deadline is March 8, 2027, and no receipts are required to file.

Why it matters

If you bought generic drugs in the U.S. from 2009 to 2019, you may be owed money from these settlements.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$565.5M
Total settlement funds
Sandoz ($469M) plus Glenmark, Lannett, Bausch, Apotex, Heritage, Emcure ($96.5M)
48
States and territories in coalition
Bipartisan coalition led by California
10
Years of purchases covered
May 2009 to December 2019

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

August 2026 March 2027

5 events Latest: Today
Tap a bar to jump to that date
  1. Claims deadline

    Upcoming Deadline

    Deadline for consumers to file claims for compensation from the settlement funds.

Scenarios

1

Consumers receive settlement payments

Likely Resolves by End of 2027

Discussed by: State attorneys general, court filings

After the March 8, 2027 claims deadline, the claims administrator reviews submissions and the court grants final approval. Eligible consumers receive payments via PayPal, Venmo, Zelle, or mailed check.

2

Objections delay or modify the distribution plan

Possible Resolves by Oct 31, 2027

Discussed by: Court filings, consumer advocates

Consumers or other parties can file objections by August 14, 2027. The court may modify the plan, delay payments, or hold hearings on the objections.

3

Trial leads to additional settlements

Possible Resolves by Q2 2027

Discussed by: State attorneys general press releases

The first trial against remaining drug manufacturers begins in February 2027. The trial could lead to additional settlements, expanding the consumer restitution fund.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1999

Vitamin price-fixing cartel (1999)

Hoffmann-La Roche and BASF pleaded guilty to fixing prices of vitamins sold worldwide. Roche paid $500 million and BASF paid $225 million in criminal fines, the largest antitrust penalties at the time.

Then

The companies paid over $1 billion in total fines and faced civil lawsuits from customers.

Now

The case showed that global price-fixing conspiracies could be prosecuted in U.S. courts and set a precedent for large antitrust fines.

Why this matters now

Demonstrates how large-scale price-fixing conspiracies are prosecuted and how restitution reaches affected buyers.

2021-2022

Opioid settlement distributions (2021-2022)

Johnson & Johnson and three drug distributors agreed to pay up to $26 billion to settle claims that they fueled the opioid crisis. States and local governments received funds through structured distribution plans.

Then

States received billions for addiction treatment and prevention programs.

Now

Established a model for state attorneys general managing large-scale consumer and community restitution.

Why this matters now

Shows how state attorneys general distribute large settlement funds through structured plans.

Sources

(10)